Evidence map›Paper›PMID 37523349›Full record

ReviewPLOS global public health2023

Rethinking communications for governance of malaria programs.

Jimmy Opigo, Anya L Guyer

Abstract readReview
In one paragraph

Review in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jimmy OpigoNational Malaria Control Division, Ministry of Health, Kampala, Republic of Uganda.ORCID https://orcid.org/0009-0003-1521-4159
Anya L GuyerConsultant, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-7948-5287

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria has, to a great extent, become normalized and accepted as inevitable. To resume global progress on malaria elimination, national malaria programs in many malaria-endemic countries urgently need to add new tactics. The global COVID-19 experience has demonstrated that it is possible to rapidly shift health programming and governance. In this essay we argue that a key to transforming malaria programming is stronger and more strategic communications to bring malaria to the forefront. Our concept of communications goes beyond the typical malaria behavior change communication or information, education and communication campaigns; to truly have an impact on improving the malaria situation in the countries where it is most entrenched, malaria program staff and advocates must also focus more on strategic communications to rally the full range of stakeholders to prioritize malaria. We searched two databases of peer-reviewed literature and one malaria-focused journal for examinations of strategic communications for malaria governance and found no publications that deal directly with the topic. This paper therefore proposes a framework for strategic communications for malaria governance that involves five key elements: knowing the audience, defining the message, designing a medium, identifying a messenger, and selecting the timing. Throughout the essay, we draw on experiences from Uganda, where one of the authors leads the country's National Malaria Control Division. Strategic communications can trigger improvements in malaria control by driving and supporting decision-making by individuals and leaders. Further, strategic communications is a tool used to improve policy, mobilize resources, and serve as the management glue that holds a malaria program and team together as they move their nations towards malaria elimination.

Identifiers

PMID37523349
PMCPMC10389711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.